Comparison of gastric peristalsis inhibition by scopolamine butylbromide and glucagon: Evaluation by electrogastrography and analysis of heart rate variability

Journal of Gastroenterology

Volumn 38, Issue 7, 2003, Pages 629-635

  Katoh, Kansei ^a   Nomura, Masahiro ^a   Iga, Akiko ^a   Hiasa, Aya ^a   Uehara, Kohzou ^a   Harada, Kenji ^a   Nakaya, Yutaka ^a   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Analysis of heart rate variability; Electrogastrography; Gastric peristalsis; Glucagon; Scopolamine butylbromide

Indexed keywords

CATECHOLAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; GLUCAGON; GLUCAGON RECEPTOR; SCOPOLAMINE BUTYL BROMIDE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CARDIOVASCULAR DISEASE; CATECHOLAMINE BLOOD LEVEL; CHOLINERGIC ACTIVITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; ELECTROGASTROGRAPHY; FEMALE; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART PALPITATION; HEART RATE VARIABILITY; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LUNG DISEASE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER MEMBRANE; SPECTROSCOPY; STOMACH MOTILITY; SYMPATHETIC TONE; URINARY TRACT DISEASE; VISUAL IMPAIRMENT;

ADULT; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; BUTYLSCOPOLAMMONIUM BROMIDE; CATECHOLAMINES; CHOLINERGIC ANTAGONISTS; ELECTRODIAGNOSIS; FEMALE; GASTROINTESTINAL AGENTS; GLUCAGON; HEART RATE; HUMANS; MALE; PERISTALSIS; STOMACH;

EID: 0041561182     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1114-y     Document Type: Article

References (30)

1. Grainger SL, Smith SE. Dose-response relationships of intravenous hyoscine butylbromide and atropine sulphate on heart rate in healthy volunteers. Br J Clin Pharmacol 1983;16:623-6.
2. Pfeiffer A, Kaess H, Bodeker RH, Schwantes U. Heart rate increase after intravenous administration of trospium chloride and scopolamine during endoscopic retrograde cholangiopancreatography. Endoscopy 1998;30:580.
3. Dotevall G, Kock NG, Walan A. Inhibition of basal gastric acid secretion in man by glucagon given intraportally. Scand J Gastroenterol 1970;5:391-4.
4. Kreel L. Pharmaco-radiology in barium examinations with special reference to glucagons. Scand J Gastroenterol 1972;63: 392-8.
5. Fasth S, Hulten L. The effect of glucagon on intestinal motility and blood flow. Acta Physiol Scand 1971;83:169-73.
6. Cohen ML, Wiley KS, Yaden E, Slater IH. In vitro actions of somatostatin, D-Val1, D-Trp8-somatostatin and glucagon in rabbit jejunum and guinea-pig ileum. J Pharmacol Exp Ther 1979; 211:423-9.
7. Lieberman DA, Wuerker CK, Katon RM. Cardiopulmonary risk of esophagogastroduodenoscopy: role of endoscope diameter and systemic sedation. Gastroenterology 1985;88:468-72.
8. Switz DM, Clarke AM, Longacher JW. Electrical malfunction at endoscopy: possible cause of arrhythmia and death. JAMA 1976;235:273-5.
9. Santamaria L, de Miguel E. Localization of glucagon receptors in intestinal and vascular smooth muscle fibers in the dog: use of autoradiographic technics (in Spanish). Rev Esp Enferm Apar Dig 1985;67:301-8.
10. Santamaria L, de Miguel E, Codesal J, Ramirez JR, Picazo J. Identification of glucagon binding sites on smooth muscle tissue of dog intestine: quantification by means of ultrastructural autoradiography. Anat Anz 1991;172:149-57.
11. Mintchev MP, Kingma YJ, Bowes KL. Accuracy of cutaneous recordings of gastric electrical activity. Gastroenterology 1993; 104:1273-80.
12. Chen JD, McCallum RW. Clinical applications of electrogastrography. Am J Gastroenterol 1993;88:1324-36.
13. Parkman HP, Harris AD, Krevsky B, Urbain JL, Maurer AH, Fisher RS. Gastroduodenal motility and dysmotility: an update on techniques available for evaluation. Am J Gastroenterol 1995;90: 869-92.
14. Miyajima H, Nomura M, Muguruma N, Okahisa T, Shibata H, Okamura S, et al. Relationship among gastric motility, autonomic activity, and portal hemodynamics in patients with liver cirrhosis. J Gastroenterol Hepatol 2001:16:647-59.
15. Vybiral T, Bryg RJ, Maddens ME, Boden WE. Effect of passive tilt on sympathetic and parasympathetic components of heart rate variability in normal subjects. Am J Cardiol 1989;63: 1117-20.
16. Furlan R, Guzzetti S, Crivellaro W, Dassi S, Tinelli M, Baselli G, et al. Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects. Circulation 1990;81:537-47.
17. Hayano J, Sakakibara Y, Yamada A, Yamada M, Mukai S, Fujinami T, et al. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects. Am J Cardiol 1991;67: 199-204.
18. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation 1994;90:234-40.
19. Lawrence AM. Glucagon in medicine: new ideas for an old hormone. Med Clin North Am 1970;54:183-90.
20. Lawrence AM. Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. Proc Natl Acad Sci U S A 1996;55:316-20.
21. Pacchioni M, Orena C, Panizza P, Cucchi E, Del Maschio A, Pontiroli AE. The hypotonic effect of intranasal and intravenous glucagon in gastrointestinal radiology. Abdom Imaging 1995;20: 44-6.
22. Miller RE, Chernish SM, Brunelle RL, Rosenak BD. Dose response to intramuscular glucagon during hypotonic radiography. Radiology 1978;127:49-53.
23. Mochiki E, Suzuki H, Takenoshita S, Nagamachi Y, Kuwano H, Mizumoto A, et al. Mechanism of inhibitory effect of glucagon on gastrointestinal motility and cause of side effects of glucagon. J Gastroenterol 1998;33:835-41.
24. Hradsky M, Stockbrugger R, Dotevall G, Ostberg H. The use of glucagon during upper gastrointestinal endoscopy. Gastrointest Endosc 1974:20:162.
25. Melsom M, Myren J, Larsen S, Moe A. Comparison of glucagon and pethidine plus atropine as premedication for peroral endoscopy: a double blind study. Endoscopy 1977;9:79-82.
26. Stunkard AJ, Van Itallie TB, Reis BB. The mechanism of satiety: effect of glucagons on gastric hunger contractions in man. Proc See Exp Biol Med 1955;89:258-61.
27. Anuras S, Cooke AR. Effects of some gastrointestinal hormones on two muscle layers of duodenum. Am J Physiol 1978;234:E60-3.
28. Gagnon G, Regoli D, Rioux F. Studies on the mechanism of action of glucagon in strips of rabbit renal artery. Br J Pharmacol 1980;69:389-96.
29. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992;85:164-71.
30. Hashimoto T, Adachi K, Ishimura N. Hirakawa K, Katsube T, Kurotani A, et al. Safety and efficacy of glucagon as a premedication for upper gastrointestinal endoscopy - a comparative study with butyl scopolamine bromide. Aliment Pharmacol Ther 2002; 16:111-8.